We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. Allarity Therapeutics Inc is a clinical-stage, precision medicine company.
Boston (February 6, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a...
Boston (January 30, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer...
Two patients exceed 14 months on treatment in Phase 2 trial of advanced ovarian cancerAllarity maintains a cash balance of $18.5 million, sufficient to advance and accelerate stenoparib’s...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.375 | -26.5957446809 | 1.41 | 1.41 | 0.9701 | 1836924 | 1.11711308 | CS |
4 | -0.015 | -1.42857142857 | 1.05 | 1.99 | 0.961 | 2278159 | 1.29731511 | CS |
12 | -0.415 | -28.6206896552 | 1.45 | 1.99 | 0.9 | 1629534 | 1.17795709 | CS |
26 | -3.6 | -77.6699029126 | 4.635 | 6 | 0.9 | 1389945 | 2.47659234 | CS |
52 | -269.265 | -99.6170921199 | 270.3 | 282.9 | 0.9 | 3003151 | 18.50019335 | CS |
156 | 167143.474062 | -100.000619232 | -167142.439062 | 92640 | -157613.42069 | 1958611 | 1504.77852602 | CS |
260 | 250334.824414 | -100.000413448 | -250333.789414 | 92640 | -167332.373652 | 1880475 | 1315.39108112 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions